Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, used for the treatment of multiple sclerosis. Fingolimod is a sphingosine-1-phosphate...
27 KB (2,539 words) - 05:53, 26 March 2024
secondary lymphs. Furthermore, fingolimod was found to modulate receptors 1-5 of the sphingosine-1-phosphate class. Fingolimod is the first-in-class discovered...
14 KB (1,581 words) - 16:44, 1 February 2024
Sphingolipidoses General structures of sphingolipids Dimethylsphingosine Fingolimod Radin N (2003). "Killing tumours by ceramide-induced apoptosis: a critique...
4 KB (219 words) - 13:26, 11 May 2024
pharmaceutical formulations, particularly in the cases of active ingredients like fingolimod, which is used to treat multiple sclerosis. A notable method for synthesizing...
10 KB (994 words) - 06:26, 12 November 2023
established through the clinical work performed during development of fingolimod (trade name Gilenya), a non‐selective S1P modulator.[better source needed]...
33 KB (3,240 words) - 13:34, 27 January 2024
Multiple sclerosis drug pipeline (section Fingolimod)
fumarate itself, (Bafiertam), approved in April 2020. Four S1P modulators: Fingolimod (Gilenya), an oral treatment and the first oral therapy approved for multiple...
83 KB (9,409 words) - 23:31, 26 April 2024
5541 CYM-50260 CYM-50308 Dihydro-S1P (sphinganine 1-phosphate) Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001...
29 KB (3,310 words) - 03:20, 2 February 2024
remyelination after injury or disease. Immunomodulatory drugs such as fingolimod have been shown to reduce immune-mediated damage to the CNS, preventing...
24 KB (2,701 words) - 21:14, 9 March 2024
during a 4-year course of dimethyl fumarate, developed PML and died. Fingolimod (Gilenya) was approved in 2010 by the FDA for MS. In 2015, the first case...
23 KB (2,414 words) - 19:20, 9 February 2024
degeneration. There are 5 types of Sphingosine-1-phosphate receptor. The drug fingolimod (FTY720), which agonizes the S1P receptor, prevents autoimmune lymphocytes...
24 KB (2,604 words) - 16:08, 19 March 2024
in Penicillium stoloniferum. Thermophilic fungi were the source of the fingolimod precursor myriocin. Aspergillus synthesizes immunosuppressants gliotoxin...
19 KB (1,718 words) - 19:43, 22 April 2024
roughly equivalent to that of adults. The role of some newer agents such as fingolimod, teriflunomide, and dimethyl fumarate, is not yet entirely clear. Making...
164 KB (17,366 words) - 22:18, 9 May 2024
Galvus (vildagliptin) Diabetes mellitus type 2 910 2012 39% Gilenya (fingolimod) Multiple sclerosis 1,195 2012 142% Gleevec/Glivec (imatinib) Oncology...
142 KB (11,963 words) - 08:25, 3 May 2024
potent than ciclosporin.[citation needed] The multiple sclerosis drug fingolimod was derived from myriocin by using structure–activity relationship studies...
4 KB (162 words) - 17:25, 1 March 2024
in combination with ciclosporin or tacrolimus in transplant patients. Fingolimod is a synthetic immunosuppressant. It increases the expression or changes...
29 KB (3,309 words) - 04:27, 30 January 2024
on lymphocytes and other cell types. Siponimod may be very similar to fingolimod but preventing lymphopenia, one of its main side effects, by preventing...
11 KB (798 words) - 14:37, 24 April 2024
PMID 22264485. Groves, Aran; Kihara, Yasuyuki; Chun, Jerold (2013-05-15). "Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation...
12 KB (1,266 words) - 08:05, 18 August 2023
5541 CYM-50260 CYM-50308 Dihydro-S1P (sphinganine 1-phosphate) Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001...
11 KB (682 words) - 03:02, 3 May 2024
Sphingosyl phosphatide Chun J, Hartung HP (2010). "Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis". Clinical Neuropharmacology. 33 (2): 91–101...
24 KB (2,744 words) - 01:03, 10 January 2024
nymphs of cicadas. It produces myriocin, from which the synthetic drug fingolimod, a treatment for multiple sclerosis, was developed. Isaria sinclairii...
8 KB (683 words) - 16:18, 10 January 2024
Filspari Filsuvez fimasartan (INN) Finacea (Bayer) finasteride (INN) fingolimod (USAN) Finlee Fioricet (Actavis) Fiorinal (Actavis) fipexide (INN) firategrast...
2 KB (185 words) - 07:03, 27 December 2023
5541 CYM-50260 CYM-50308 Dihydro-S1P (sphinganine 1-phosphate) Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001...
11 KB (1,140 words) - 01:30, 25 March 2024
5541 CYM-50260 CYM-50308 Dihydro-S1P (sphinganine 1-phosphate) Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001...
24 KB (2,403 words) - 21:12, 4 March 2024
Olokizumab L04AD01 Ciclosporin L04AD02 Tacrolimus L04AD03 Voclosporin L04AE01 Fingolimod L04AE02 Ozanimod L04AE03 Siponimod L04AE04 Ponesimod L04AE05 Etrasimod...
3 KB (367 words) - 15:37, 25 January 2024
history of relapsing forms of multiple sclerosis, after four years of using fingolimod (also known by its brand name Gilenya), another drug used to treat relapsing...
20 KB (2,616 words) - 16:45, 29 April 2024
that certain immunosuppressants used to treat MS—such as interferon-β, fingolimod, natalizumab, and alemtuzumab—worsen NMO disease progression and should...
68 KB (7,255 words) - 03:07, 5 February 2024
Deucravacitinib Efgartigimod alfa (+hyaluronidase) Etrasimod Filgotinib Fingolimod Guselkumab Iptacopan Itacitinib Ixekizumab Netakimab Olokizumab Ozanimod...
7 KB (299 words) - 13:45, 27 April 2024
patient's quality of life. PRIMUS has been used to assess the efficacy of fingolimod and rivastigmine. Doward, LC; McKenna, S.P.; Meads, D.M.; Twiss, J; Eckert...
7 KB (752 words) - 16:24, 3 December 2023
5541 CYM-50260 CYM-50308 Dihydro-S1P (sphinganine 1-phosphate) Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001...
3 KB (328 words) - 13:29, 26 August 2023
considered to be too low to be of clinical importance in a study. Like fingolimod, which is already approved for the treatment of multiple sclerosis, ponesimod...
15 KB (1,066 words) - 05:36, 26 March 2024